Phase 3 study for people with Leukaemia

Recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 3
Sponsor BeOne Medicines
Registry number NCT06846671
Started 10 April 2025 Today 16 October 2026 Estimated completion 15 May 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Concord Repatriation General Hospital Concord NSW Recruiting
Gosford Hospital Gosford NSW Recruiting
Port Macquarie Base Hospital Port Macquarie NSW Recruiting
Prince of Wales Hospital Randwick NSW Recruiting
Toowoomba Hospital Toowoomba QLD Recruiting
Flinders Medical Centre Bedford PK SA Recruiting
The Alfred Hospital Melbourne VIC Recruiting
Perth Blood Institute West Perth WA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 250

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1. Confirmed diagnosis of CLL or SLL, requiring treatment, based on 2018 international workshop on chronic lymphocytic leukemia (iwCLL) criteria.

2. Previously received treatment for CLL/SLL with both a BTKi and a BCL2i.

3. Participants with SLL must have measurable disease by computer tomography (CT)/magnetic resonance imaging (MRI)

4. Eastern Cooperative Oncology Group (ECOG) score 0, 1, or 2

5. Adequate liver function

6. Adequate blood clotting function

Exclusion Criteria:

1. Known prolymphocytic leukemia or history of, or currently suspected, Richter's transformation

2. Prior autologous stem cell transplant or chimeric antigen receptor-T cell therapy in the last 3 months

3. Known central nervous system involvement

4. Prior exposure to any BTK protein degraders

5. Active fungal, bacterial and/or viral infection requiring parenteral systemic therapy

6. Clinically significant cardiovascular disease

NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.

Dates on the record

Started 10 April 2025
Estimated completion 15 May 2028
Registry last updated 28 September 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 28 September 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.